Johnson & Johnson to begin testing Ebola vaccine in January

Johnson & Johnson says it could have 250,000 doses available in May, if health authorities deem it safe and promising enough to distribute more broadly.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.